deeptech Value proposition
Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems!
At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines.
At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production.
Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability of success.
In practices, our system allow for easy manufacturing of most lipidic or polymeric nanoparticles (liposomes, LNP, solid lipid nanoparticles, PLGAs...) using the same system all along your drug development process - from your screening stage at μL scale to your continuous production at 10s of L scale - while ensuring ultimate nanoparticle characteristics control at every step of the process.
Our TAMARA nanoparticle formulation system meets these challenges head-on, offering a comprehensive, all-in-one R&D platform that supports every phase of development, from initial screening to in-vivo studies. With zero dead volumes and reusable microfluidic chips, TAMARA is the ultimate solution for RNA-LNP or nanomedicine development.
But don’t just take our word for it—our users say it best: “I’m absolutely blown away by how user-friendly, efficient, and straightforward this system is!”
instruments, microfluidics, nanotechnology, engineering, biotech, Pharma, Pharmaceutical, RNA, LNP, Nanoparticles, RNA-LNP, and LiposomesOriginal language
Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems!
At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines.
At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production.
Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability of success.
In practices, our system allow for easy manufacturing of most lipidic or polymeric nanoparticles (liposomes, LNP, solid lipid nanoparticles, PLGAs...) using the same system all along your drug development process - from your screening stage at μL scale to your continuous production at 10s of L scale - while ensuring ultimate nanoparticle characteristics control at every step of the process.
Our TAMARA nanoparticle formulation system meets these challenges head-on, offering a comprehensive, all-in-one R&D platform that supports every phase of development, from initial screening to in-vivo studies. With zero dead volumes and reusable microfluidic chips, TAMARA is the ultimate solution for RNA-LNP or nanomedicine development.
But don’t just take our word for it—our users say it best: “I’m absolutely blown away by how user-friendly, efficient, and straightforward this system is!”
Inside Therapeutics - LNP and nanoparticle manufacturing specialist
We revolutionize nanoparticle manufacturing by offering intuitive platforms to accelerate and scale-up the LNP-RNA vaccines development.
https://insidetx.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 ADEME National and local authorities, Environmental Services | ADEME National and local authorities, Environmental Services | Other 28 Sep 2024 | | |
 Covivio Real Estate | Covivio Real Estate | Other 6 Aug 2024 | | |
 ADI Nouvelle-Aquitaine Business Consulting and Services | ADI Nouvelle-Aquitaine Business Consulting and Services | Other 24 May 2024 | | |
 SPN (réSeau des Professionnels du Numérique et de l'image) IT Services and IT Consulting | SPN (réSeau des Professionnels du Numérique et de l'image) IT Services and IT Consulting | Other 24 May 2024 | | |
 Schneider Electric Electricals, Appliances, Electrical, and Electronics Manufacturing | Schneider Electric Electricals, Appliances, Electrical, and Electronics Manufacturing | Other 24 May 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 5 Apr 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 9 Feb 2024 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 22 Jan 2024 | | |
 Maddyness Media, Media Production | Maddyness Media, Media Production | Other 8 Jan 2024 | | |
 Réseau Canopé Government Administration | Réseau Canopé Government Administration | Other 21 Dec 2023 | | |